Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Bladder Dysfunction Reports
Erschienen in: Current Bladder Dysfunction Reports 3/2013

01.09.2013 | Inflammatory/Infectious Bladder Conditions (S Mourad, Section Editor)

Prostate Related Urinary Tract Infections

verfasst von: David Osborn, Melissa Kaufman, W. Stuart Reynolds, Roger Dmochowski

Erschienen in: Current Bladder Dysfunction Reports | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Usually both acute and chronic bacterial prostatitis can be successfully treated with a 28-day course of fluoroquinolones. However, a significant portion of men will develop a recurrent infection. Host factors such as diabetes and urinary tract manipulation predispose patients to develop chronic bacterial prostatitis or an abscess. Pathogen factors such as the ability to form a biofilm and antibiotic resistance also lead to failures. Difficulty achieving adequate antibiotic concentration in prostatic tissue and more virulent bacteria are just two of the factors that make the treatment of chronic bacterial prostatitis more complex and less successful than the treatment of acute bacterial prostatitis. Increasing resistance to fluoroquinolones among bacteria in the Enterobacteraceae family may make treating chronic bacterial prostatitis even more challenging in the future.
Literatur
1.
Krieger JN, Ross SO, Simonsen JM. Urinary tract infections in healthy university men. J Urol. 1993;149:1046–8.PubMed
2.
la Rosette de JJ, Hubregtse MR, Meuleman EJ, et al. Diagnosis and treatment of 409 patients with prostatitis syndromes. Urology. 1993;41:301–7.CrossRef
3.
Lipsky BA. Urinary tract infections in men. Epidemiology, pathophysiology, diagnosis, and treatment. Ann Intern Med. 1989;110:138–50.PubMedCrossRef
4.
Cohen J, Powderly WG, Opal SM. Infectious Diseases. Philadelphia, PA: Mosby Incorporated; 2010.
5.
•• Yoon BI, Kim S, Han D-S, et al. Acute bacterial prostatitis: how to prevent and manage chronic infection? J Infect Chemother. 2012;18:444–50. Excellent retrospective study that, looks for factors that predispose patients to developing chronic bacterial prostatitis.PubMedCrossRef
6.
Ha U-S, Kim ME, Kim CS, et al. Acute bacterial prostatitis in Korea: clinical outcome, including symptoms, management, microbiology and course of disease. Int J Antimicrob Agents. 2008;31 Suppl 1:S96–S101.PubMedCrossRef
7.
Millan-Rodriguez F, Palou J, Bujons-Tur A, et al. Acute bacterial prostatitis: two different sub-categories according to a previous manipulation of the lower urinary tract. World J Urol. 2006;24:45–50.PubMedCrossRef
8.
Blacklock NJ. The anatomy of the prostate: relationship with prostatic infection. Infection. 1991;19 Suppl 3:S111–4.PubMedCrossRef
9.
Hua L-X, Zhang J-X, Wu H-F, et al. The diagnosis and treatment of acute prostatitis: report of 35 cases. Zhonghua Nan Ke Xue. 2005;11:897–9.PubMed
10.
• Nagy V, Kubej D. Acute bacterial prostatitis in humans: current microbiological spectrum, sensitivity to antibiotics and clinical findings. Urol Int. 2012;89:445–50. Retrospective review of 192 patients with acute bacterial prostatitis.PubMedCrossRef
11.
• Minamida S, Satoh T, Tabata K, et al. Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy. Urology. 2011;78:1235–9. Excellent study that examined the important issue of increasing resistance of Escherichia coli.PubMedCrossRef
12.
Neal DEJ, Clejan S, Sarma D, Moon TD. Prostate specific antigen and prostatitis. I. Effect of prostatitis on serum PSA in the human and nonhuman primate. Prostate. 1992;20:105–11.PubMedCrossRef
13.
Kravchick S, Cytron S, Agulansky L, Ben-Dor D. Acute prostatitis in middle-aged men: a prospective study. BJU Int. 2004;93:93–6.PubMedCrossRef
14.
Becopoulos T, Georgoulias D, Constantinides C, et al. Acute prostatitis: which antibiotic to use first. J Chemother. 1990;2:244–6.PubMed
15.
16.
Lindert KA, Kabalin JN, Terris MK. Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy. J Urol. 2000;164:76–80.PubMedCrossRef
17.
Krieger JN, Nyberg LJ, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA. 1999;282:236–7.PubMedCrossRef
18.
Stamey TA, Meares EM, Winningham DG. Chronic bacterial prostatitis and the diffusion of drugs into prostatic fluid. J Urol. 1970;103:187–94.PubMed
19.
Nickel JC: (2011). Campbell-Walsh Urology 10th Edition Review. Edited by McDougal WS, Wein AJ, Kavoussi LR, et al. Philadelphia, PA: Saunders; 2011: 327-356.
20.
Wise GJ, Shteynshlyuger A. How to diagnose and treat fungal infections in chronic prostatitis. Curr Urol Rep. 2006;7:320–8.PubMedCrossRef
21.
Meares EM, Stamey TA. Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol. 1968;5:492–518.PubMed
22.
McNaughton Collins M, Fowler FJJ, Elliott DB, et al. Diagnosing and treating chronic prostatitis: do urologists use the four-glass test? Urology. 2000;55:403–7.PubMedCrossRef
23.
Andrews SJ, Brooks PT, Hanbury DC, et al. Ultrasonography and abdominal radiography versus intravenous urography in investigation of urinary tract infection in men: prospective incident cohort study. BMJ. 2002;324:454–6.PubMedCrossRef
24.
Schaeffer AJ. Review of norfloxacin in complicated and recurrent urinary tract infections. Eur Urol. 1990;17 Suppl 1:19–23.PubMed
25.
Weidner W, Schiefer HG, Brähler E. Refractory chronic bacterial prostatitis: a re-evaluation of ciprofloxacin treatment after a median follow-up of 30 months. J Urol. 1991;146:350–2.PubMed
26.
Naber KG, Busch W, Focht J. Ciprofloxacin in the treatment of chronic bacterial prostatitis: a prospective, non-comparative multicentre clinical trial with long-term follow-up. The German Prostatitis Study Group. Int J Antimicrob Agents. 2000;14:143–9.PubMedCrossRef
27.
Wagenlehner FM, Naber KG. Antimicrobial treatment of prostatitis. Expert Rev Anti Infect Ther. 2003;1:275–82.PubMedCrossRef
28.
Krieger JN, Ross SO, Limaye AP, Riley DE. Inconsistent localization of gram-positive bacteria to prostate-specific specimens from patients with chronic prostatitis. Urology. 2005;66:721–5.PubMedCrossRef
29.
Krieger JN, McGonagle LA. Diagnostic considerations and interpretation of microbiological findings for evaluation of chronic prostatitis. J Clin Microbiol. 1989;27:2240–4.PubMed
30.
• Perletti G, Skerk V, Magri V, et al. Macrolides for the treatment of chronic bacterial prostatitis: an effective application of their unique pharmacokinetic and pharmacodynamic profile (Review). Mol Med Rep. 2011;4:1035–44. Authors propose that macrolides should be used more to treat bacterial prostatitis because of their excellent pharmacokinetic and pharmacodynamic properties.PubMed
31.
El-Hakim A. Chronic prostatitis/chronic pelvic pain syndrome: is there a role for local drug infiltration therapy? J Endourol. 2004;18:227–31.PubMedCrossRef
32.
• Kolumbic Lakos A, Skerk V, Malekovic G, et al. A switch therapy protocol with intravenous azithromycin and ciprofloxacin combination for severe, relapsing chronic bacterial prostatitis: a prospective non-comparative pilot study. J Chemother. 2011;23:350–3. Prospective study that successfully gave chronic bacterial prostatitis patients parenteral antibiotics prior to oral antibiotics.PubMed
33.
Barnes RW, Hadley HL, O'Donoghue EP. Transurethral resection of the prostate for chronic bacterial prostatitis. Prostate. 1982;3:215–9.PubMedCrossRef
34.
Nickel JC, Costerton JW, McLean RJ, Olson M. Bacterial biofilms: influence on the pathogenesis, diagnosis and treatment of urinary tract infections. J Antimicrob Chemother. 1994;33(Suppl A):31–41.PubMedCrossRef
35.
Barozzi L, Pavlica P, Menchi I, et al. Prostatic abscess: diagnosis and treatment. AJR Am J Roentgenol. 1998;170:753–7.PubMedCrossRef
36.
Ludwig M, Schroeder-Printzen I, Schiefer HG, Weidner W. Diagnosis and therapeutic management of 18 patients with prostatic abscess. Urology. 1999;53:340–5.PubMedCrossRef
37.
Kinahan TJ, Goldenberg SL, Ajzen SA, Cooperberg PL, English RA. Transurethral resection of prostatic abscess under sonographic guidance. Urology. 1991;37:475–7.PubMedCrossRef
38.
Bachor R, Gottfried HW, Hautmann R. Minimal invasive therapy of prostatic abscess by transrectal ultrasound-guided perineal drainage. Eur Urol. 1995;28:320–4.PubMed
39.
Trauzzi SJ, Kay CJ, Kaufman DG, Lowe FC. Management of prostatic abscess in patients with human immunodeficiency syndrome. Urology. 1994;43:629–33.PubMedCrossRef
40.
Orakwe JC, Okafor PIS. Genitourinary tuberculosis in Nigeria; a review of thirty-one cases. Niger J Clin Pract. 2005;8:69–73.PubMed
41.
Thornhill BA, Morehouse HT, Coleman P, Hoffman-Tretin JC. Prostatic abscess: CT and sonographic findings. AJR Am J Roentgenol. 1987;148:899–900.PubMedCrossRef
42.
Washecka R, Rumancik WM. Prostatic abscess evaluated by serial computed tomography. Urol Radiol. 1985;7:54–6.PubMedCrossRef
43.
Granados EA, Riley G, Salvador J, Vincente J. Prostatic abscess: diagnosis and treatment. J Urol. 1992;148:80–2.PubMed
44.
Varkarakis J, Sebe P, Pinggera G-M, et al. Three-dimensional ultrasound guidance for percutaneous drainage of prostatic abscesses. Urology. 2004;63:1017–20. discussion 1020.PubMedCrossRef
Metadaten
Titel
Prostate Related Urinary Tract Infections
verfasst von
David Osborn
Melissa Kaufman
W. Stuart Reynolds
Roger Dmochowski
Publikationsdatum
01.09.2013
Verlag
Springer US
Erschienen in
Current Bladder Dysfunction Reports / Ausgabe 3/2013
Print ISSN: 1931-7212
Elektronische ISSN: 1931-7220
DOI
https://doi.org/10.1007/s11884-013-0194-7

Weitere Artikel der Ausgabe 3/2013

Current Bladder Dysfunction Reports 3/2013 Zur Ausgabe

Inflammatory/Infectious Bladder Conditions (S Mourad, Section Editor)

Genital Filariasis Review

Post-Prostatectomy and Acquired Voiding Dysfunction (C Comiter, Section Editor)

Benign Prostate Hyperplasia and Bladder Stones: An Update

Post-Prostatectomy and Acquired Voiding Dysfunction (C Comiter, Section Editor)

Urinary Retention and Incontinence after Low-Dose-Rate Brachytherapy for Prostate Cancer

Inflammatory/Infectious Bladder Conditions (S Mourad, Section Editor)

Management of Recurrent Neurogenic Bladder Cystitis

Post-Prostatectomy and Acquired Voiding Dysfunction (C Comiter, Section Editor)

The Link Between Benign Prostatic Hyperplasia and Sexual Dysfunction

Inflammatory/Infectious Bladder Conditions (S Mourad, Section Editor)

Genitourinary Tuberculosis; An Update

Neu im Fachgebiet Urologie

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise